Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02270476 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Following Newborn Screening

Study acronym: TRACK-CF
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv9
  2. Primary completion date: Dec 2021 to Dec 2030
    • Study completion date: Dec 2022 to Dec 2030
    v8
  3. 6 versions Re-verified since May 27, 2015, no change to tracked fieldsv2-v7
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to further characterize early CF lung disease in newborns, infants and toddlers with cystic fibrosis (CF).
Trial Details
NCT Number NCT02270476
Lead Sponsor Heidelberg University
Collaborators: German Center for Lung Research
Conditions
(from sponsor)		 Cystic Fibrosis Lung Disease
Related terms Cystic Fibrosis
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov